Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran

This publication has 15 references indexed in Scilit:

• Coagulation assays and plasma fibrinogen concentrations in real‐world patients with atrial fibrillation treated with dabigatran
  British Journal of Clinical Pharmacology, 2014
• New oral anticoagulants: a practical guide on prescription, laboratory testing and peri‐procedural/bleeding management
  Internal Medicine Journal, 2014
• The role of the laboratory in treatment with new oral anticoagulants
  Journal of Thrombosis and Haemostasis, 2013
• The Effect of Dabigatran on Select Specialty Coagulation Assays
  American Journal of Clinical Pathology, 2013
• Dabigatran Effects on the International Normalized Ratio, Activated Partial Thromboplastin Time, Thrombin Time, and Fibrinogen: A Multicenter, In Vitro Study
  Annals of Pharmacotherapy, 2012
• Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology
  British Journal of Haematology, 2012
• Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia
  Thrombosis Research, 2010
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation
  New England Journal of Medicine, 2009
• Dabigatran Etexilate
  Drugs, 2008
• Inaccuracy of the ‘derived’ fibrinogen measurement
  Blood Coagulation & Fibrinolysis, 1994